Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q2- Text added to 2014 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
New words:
accommodate, add, agent, AGT, angiotensinogen, burden, cessation, concurrent, contemplated, CTA, cutoff, distance, duration, glycolate, hospitalization, hyperoxaluria, hypertensive, infrequent, intention, longest, MD, median, mortality, onForm, oxidase, past, preeclampsia, pregnancy, requisite, revusiran, robust, SAD, subgroup, tetramer, unchanged, walk
Removed:
April, BLA, carried, closely, Cosmetic, deficiency, GSK, led, pharmacodynamic, reclassify, regulated, Union
Valuein 2014 Q2 filing- Value in 2014 Q3 filing
Original filings
Filing view